IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response
Interleukin-1 receptor antagonist (IL1RA) is an anti-inflammatory and anti-tumor protein, and a member of the Interleukin-1 (IL-1) family. Our previous finding showed that IL1RA is a tumor marker for oral squamous cell carcinoma (OSCC), but the exact mechanism is unknown. The present study aims to i...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2025-08-01
|
| Серія: | Translational Oncology |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1936523325001597 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|